Northpond Ventures II LP 13D/13G Filings for CAMP4 Therapeutics Corporation (CAMP)

Northpond Ventures II LP 13D and 13G filings for CAMP4 Therapeutics Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-22
6:49 pm
Purchase
2024-10-1513GCAMP4 Therapeutics Corporation
CAMP
Northpond Ventures II LP2,238,244
11.500%
2,238,244increase
(New Position)
Filing